STEPHANIE ANN TOMASEK
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BELTON, TX NPI 1730385261
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TX Novo Nordisk AS All categories
General Payments — all program years on this page
$1,301.68
- Category: General Payments
- Program years: PY2021–2024
- Record count: 62
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $218.52 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $218.52 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $99.51 | 5 |
| Lilly USA, LLC | $56.72 | 1 |
| Exact Sciences Corporation | $26.56 | 1 |
| DEXCOM, INC. | $19.90 | 1 |
| GlaxoSmithKline, LLC. | $15.83 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100340268 | Novo Nordisk Inc | $18.30 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100374709 | Novo Nordisk Inc | $15.70 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100387189 | Novo Nordisk Inc | $23.10 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100499167 | Novo Nordisk Inc | $22.45 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100547936 | Novo Nordisk Inc | $19.96 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114424884 | Exact Sciences Corporation | $26.56 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116051161 | GlaxoSmithKline, LLC. | $15.83 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135958583 | Lilly USA, LLC | $56.72 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153387738 | Dexcom, Inc. | $19.90 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.